Thyroid Cancer: Insights into Diagnosis & Treatment

OR14-1

Midkine Concentration in FNA Washout: a Novel Diagnostic Approach to Identify Papillary Thyroid Carcinoma
Youn Hee Jee, Francesco S. Celi, Electron Kebebew, Maureen Sampson, David B. Sacks, Alan Remaley and Jeffrey Baron

OR14-3

Advantages and disadvantages of prophylactic central compartment lymph node dissection for differentiated thyroid cancer: the first randomized controlled study from a single referral center
David Viola, Laura Valerio, Pinuccia Faviana, Eleonora Molinaro, Elisa Sensi, Laura Agate, Gabriele Materazzi, Fulvio Basolo, Paolo Miccoli, Paolo Vitti and Rossella Elisei

OR14-4

Does BRAF V600E Mutation Predict Aggressive Features in Classic Papillary Thyroid Cancer? Results from Four Endocrine Surgery Centers
Carol Li, Patricia A. Han, Kathleen C. Lee, Louis C. Lee, Amy C. Fox, Toni Beninato, Michele Thiess, Thomas J Sebo, Geoffrey B Thompson, Clive S. Grant, Thomas J Giordano, Paul G. Gauger, Gerard M. Doherty, Thomas J. Fahey III, Justin Bishop, James R. Eshleman, Christopher B Umbricht, Eric B. Schneider and Martha A. Zeiger

OR14-5

Salvage therapy with tyrosine kinase inhibitors (TKIs) for differentiated thyroid carcinoma (DTC) after first line sorafenib failure
Ramona Dadu, Mimi I-Nan Hu, Mouhammed Amir Habra, Steven G Waguespack, Anita K Ying, Naifa L Busaidy and Maria E Cabanillas

OR14-6

DISTINCT GENOTYPIC SIGNATURES CORRELATE WITH MORPHOLOGY BUT DO NOT INDEPENDENTLY PREDICT BEHAVIOUR IN PAPILLARY THYROID CANCER
Karen Gomez-Hernandez, Sonia Cheng, Shereen Z Ezzat, Sylvia L. Asa and Ozgur Mete